EX-10.12 4 kura-ex1012_1160.htm EX-10.12 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2 PATENT LICENSE AGREEMENTStock Issuance Agreement • May 5th, 2020 • Michigan
Contract Type FiledMay 5th, 2020 JurisdictionThis Agreement is effective as of December 22, 2014 (the "EFFECTIVE DATE"), between Kura Oncology, Inc. ("LICENSEE") having the address in Article 12 below, and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan ("MICHIGAN"). LICENSEE and MICHIGAN hereby agree as follows:
PATENT LICENSE AGREEMENTStock Issuance Agreement • March 14th, 2017 • Kura Oncology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 14th, 2017 Company Industry JurisdictionThis Agreement is effective as of December 22, 2014 (the "EFFECTIVE DATE"), between Kura Oncology, Inc. ("LICENSEE") having the address in Article 12 below, and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan ("MICHIGAN"). LICENSEE and MICHIGAN hereby agree as follows: